HIV Antiretroviral Drugs

People infected with Hiv may advantage from micronutrient supplementation, agreeing to a report published in the February 2007, issue of the American Journal of Clinical Nutrition. The main focus of this report was with Hiv-infected persons not receiving highly active antiretroviral therapy (Haart), but also reports that added study of those receiving Haart may show benefits as well because Haart therapy is shown to deplete many micronutrients in the body.

Hiv medications are relatively easy to get in advanced countries, but only 1 in 7 in Asian countries and 1 in 10 in African countries have way to Hiv antiviral drugs. Micronutrient deficiencies are ordinarily observed in those with advanced Hiv disease and are related with higher risk of disease progression and mortality. In those receiving Haart, immunologic function is restored but these drugs do not eliminate weight loss and wasting. Because of these factors, micronutrient supplementation can be an uncostly way to heighten ability of life and perhaps cut condition care expenditures in those suffering from advanced stages of Hiv disease as well as those who continue to suffer from disease effects not treated by Haart therapy.

Drugs For Hiv

In one placebo-controlled study, Hiv-infected patients were given Vitamins A, C, and E for six months. At the starting of the test, all patients had lower levels of these prominent nutrients when compared to a group of Hiv-negative healthy volunteers. At the end of the study, the levels of these nutrients were general in the patients given supplementation and not in the placebo group. The study also showed that the supplemented group had substantially great antioxidant defenses and lower levels of oxidative stress than the placebo group.

Because Hiv medications have a direct ensue on the synthesis and metabolism of micronutrients in the body, restoring these depleted levels straight through dietary supplementation may also supply enormous advantage for those on Haart therapy. A small study showed that greater intake of Vitamin E in adults receiving Haart reduced the outcome of Haart-related complications which include body fat redistribution, dyslipidemia and insulin resistance. Other studies have been shown to stimulate glutathione peroxidase action and reduction of oxidative stress.

Such studies demonstrate the primary need for optimal nutritional maintain in Hiv-infected people. It also calls for the need of added studies to supply added validation and solutions for citizen not able to receive Haart therapy as well as to maintain and heighten the extensive condition of those who are on Haart therapy. The long-term benefits may be seen in reduced condition care expenditures, nearby the world, as well as improved ability of life for those suffering from the effects of Hiv infection.

Visit : hiv antiretroviral drugs